ArticleRSC medicinal chemistry2025

Beta-cyclodextrin formulation of a disulfide-bond disrupting agent for improved systemic exposure.

Zaafir M Dulloo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.